ABSTRACT: Membrane-active peptides that enable the triggered release of liposomal cargo are of great interest for the development of liposome-based drug delivery systems but require peptide−lipid membrane interactions that are highly defined and tunable. To this end, we have explored the possibility to use the competing interactions between membrane partitioning and heterodimerization and the folding of a set of four different de novo designed coiled coil peptides. Covalent conjugation of the cationic peptides triggered rapid destabilization of membrane integrity and the release of encapsulated species. The release was inhibited when introducing complementary peptides as a result of heterodimerization and folding into coiled coils. The degree of inhibition was shown to be dictated by the coiled coil peptide heterodimer dissociation constants, and liposomal release could be reactivated by a heterodimer exchange to render the membrane bound peptide free and thus membrane-active. The possibility to tune the permeability of lipid membranes using highly specific peptide-folding-dependent interactions delineates a new possible approach for the further development of responsive liposome-based drug delivery systems.
■ INTRODUCTION
Membrane-active peptides are an important class of functional biomolecules that are found in virtually all living organisms and are able to act as cell-penetrating agents (CPPs) 1 to facilitate cell membrane translocation or provide antimicrobial, antiviral, and antifungal activity. 2−4 The variations in amino acid composition, structure, and function of membrane-active peptides are very large, but cationic and amphipathic peptides are overrepresented, especially among antimicrobial peptides (AMPs). AMPs tend to kill bacteria by compromising the integrity of the lipid cell membrane in a pore-formation process or as a result of a detergent-like carpet mechanism. Membraneactive peptides have been extensively investigated for various therapeutic applications, including CPP-based drug delivery systems 5, 6 and as AMP-derived anti-infective drugs. 7 Natural peptides, derivatives of natural peptides, and fully synthetic and designed membrane-active peptides have been explored. 8 To increase the lipid membrane affinity of peptides with no or very little membrane activity, the lipidation of peptides with a hydrophobic moiety, such as phospholipids, cholesterol, or fatty acids, has also been extensively investigated. 9−11 The ability of membrane-active peptides to increase the permeability of lipid membranes has also been investigated as a means to release liposome-encapsulated cargo in drug delivery applications. 12−14 Liposomes are widely used in drug delivery, and low-molecular-weight drugs can often be efficiently encapsulated in either the aqueous inner compartment or in the lipid bilayer. 15 When combined with techniques for obtaining stable liposomes with long circulation times, significant improvements in drug pharmacokinetics can be achieved. 16−18 Presently there are about 10 liposome-based drug formulations in clinical use for the treatment of breast cancer, ovarian cancer, and leukemia, and a large number of liposome-based drug formulations are in various stages of clinical trials. 2, 19 Peptide-functionalization of liposomes is an important strategy in the design of drug delivery systems that recognize cell surface receptors or respond to specific enzymes, such as proteases, which can enable the more efficient and specific release of encapsulated drugs or stimulate the endocytic uptake of the liposomes. 14,20−22 However, the design of drug delivery systems exploiting peptide-mediated interactions for triggered release requires well-defined peptide−lipid interactions that can be rationally tailored and controlled. We have previously demonstrated a de novo-designed amphipathic helix−loop−helix peptide that is membrane-active only when covalently bound to a lipid membrane. 13 Furthermore, the release of liposomal cargo was inhibited upon dimerization with a complementary peptide. The inhibitory effect was downregulated by specific proteolytic digestion of the complementary peptide by matrix metalloproteinase 7 (MMP-7).
Here we show a set of de novo-designed coiled coil peptides 23, 24 that constitute a similar but more sophisticated toolbox for tailoring the permeability of liposomes. The 28-residue peptides (EI, EV, KI, and KV) with sequences based on peptides designed by Woolfson et al. 25 and Hodges et al. 26, 27 are random coils as monomers at room temperature but can heterodimerize and fold into coiled coils. Four different parallel heterodimers (EIKI, EIKV, EVKI, and EVKV) can be obtained, showing affinities for dimerization ranging from the micromolar to the picomolar range. The peptides are amphipathic, and lysine-rich KI and KV have a positive net charge at neutral pH whereas glutamic acid-rich EI and EV have a negative net charge at neutral pH. To enable covalent conjugation of the cationic peptides to lipids in liposomes, KI and KV were modified with an N-terminal Cys, yielding peptides KIC and KVC, respectively. Cationic peptides KIC and KVC were membrane-active only when covalently bound to a lipid membrane, and anchoring to liposomes leads to the rapid and peptide-concentration-dependent release of encapsulated fluorophores. KIC and KVC displayed a significant difference in the release rate and extent despite minor differences in amino acid composition. Heterodimerization with complementary peptides EI and EV inhibited the release of liposomal content. Removal of the complementary peptide by a competitive heterodimer exchange reactivated the membrane-active peptide, thus enabling a triggered release of liposomal content. The possibility to utilize highly specific peptide-folding-dependent interactions to tune the permeability of lipid membranes offers both insight into the complexity of peptide−lipid membrane interactions and an interesting approach for the further development of responsive liposome-based drug delivery systems.
■ RESULTS AND DISCUSSION
Peptide Anchoring to Liposomes and Liposome Cargo Release. Peptides EI, EV, KI, and KV are amphipathic and designed to heterodimerize and fold into coiled coils ( Figure S1 ). 23 The main driving force for folding is the burial of hydrophobic residues (Val and Ile) in the hydrophobic core. In addition, interactions between charged residues (Glu and Lys) located at the dimer interface promote the formation of heterodimers over homodimers. KI and KV were further modified with a Cys in the N-terminus to generate peptides KIC and KVC. The Cys residue enables covalent coupling of the peptides to lipids functionalized with a maleimide headgroup (MPB-PE) by means of a thiol-maleimide Michael addition. 24 In order to investigate the effects of membrane anchoring of KIC and KVC on liposome membrane integrity, 5(6)-carboxyfluorescein (CF) was encapsulated at self-quenching concentration (50 mM) in POPC liposomes with 0, 1, and 5 mol % MPB-PE ( Figure S2 ), corresponding to MPB-PE concentrations of 0, 0.4, and 2 μM, respectively. The thiol moiety in the N-terminal Cys residue of KIC and KVC can primarily react with the MPB-PE in the outer lipid leaflet, resulting in a covalent conjugation of the peptides to lipids in the liposome bilayer. Membrane permeability was exclusively increased when KIC or KVC was added to liposomes with 5 mol % MPB-PE, observed as a rapid and peptide-concentrationdependent release of encapsulated CF ( Figure 1A −C and Figure S3 ). The liposomes alone released less than 3% CF over 2 h ( Figure S4 ). In the absence of MPB-PE (0 mol %), no increase in CF release was detected upon addition of KIC or KVC nor was any release observed at 5 mol % MPB-PE when the Cys residue in the peptides was excluded ( Figure S5A,B) . Covalent anchoring of the peptides to MPB-PE in the liposomes was thus a prerequisite for the observed CF release. In addition, oxidation of the Cys residue, which results in disulfide bond formation between two peptides, precludes the binding of the peptides to MPB-PE and resulted in a drastic reduction in the release ( Figure S6 ). The experimental conditions were thus chosen to ensure that the majority of the peptides (more than 85%) would remain in their reduced form for the duration of the experiments. The rate of oxidation, determined using an Ellman's test for free thiols, 28 differed significantly for KIC and KVC. KVC remained in the reduced form for more than 8 h whereas KIC oxidized faster, and after only 1.5 h, the oxidation was about 20% when incubated at 100 μM in PBS at room temperature (RT) ( Figure S7 ). This difference in the oxidation rate is likely a consequence of the higher propensity for the homodimerization of KI in PBS as compared to KV, as previously described by Aronsson et al. 23 KIC has isoleucine (Ile) in position a and alanine (Ala) in position c in the heptad repeat whereas KVC has valine (Val) and serine (Ser) in these positions ( Figure S1 ). Because of the higher packing efficiency of Ile as compared to Val in the hydrophobic core along with the higher α-helical propensity of Ala compared to Ser, 26 KIC is more prone to homodimerization than KVC. Homodimerization of KIC and KVC leads to a closer alignment of the Cys residues in the two peptides, which facilitates intermolecular disulfide formation.
The minimum concentration needed for significant CF release (defined as twice the maximum CF release from the liposomes alone, i.e., >6%, for 5 mol % MPB-PE liposomes, Figure S4 ) was 0.1 μM for KIC and 1 μM for KVC when added to liposomes with 5 mol % MPB-PE. The release efficiency increased for KIC concentrations of up to 1 μM. However, at higher peptide concentrations the release decreased slightly to a level between 20 and 30% ( Figure 1B ). This indicates that KIC reached a threshold concentration (>1 μM) where the interaction with the lipid membrane appeared to be less favorable than homodimerization. The release caused by the addition of KVC, on the other hand, increased with increasing concentration of the peptide up to about 10 μM ( Figure 1C ). In addition to the different preferences for homodimerization, the markedly different CF release profiles for the two peptides are also likely a consequence of the small differences in hydrophobicity. The hydropathy index, as described by Kyte and Doolittle, 29 is higher for Ile (4.5) than for Val (4.2). Also, the free energy of transfer from the lipid bilayer to water measured by Wimley and White 30 showed Ile to have a more favorable environment in the lipid bilayer compared to Val (ΔG residue = 0.3 and −0.1 kcal/mol, respectively) when the residues resided in a short peptide.
Interestingly, the CF release for the liposomes with 1 mol % MPB-PE was very low, even at high concentrations of KIC or KVC. If saturated, the surface concentration of peptides on liposomes with 1 mol % MPB-PE will be more than twice the theoretical maximum for 5 mol % MPB-PE exposed to 0.2 μM KIC. However, the latter produced a significantly higher release than what was observed for liposomes with 1 mol % MPB-PE at any peptide concentration, which indicates that the number of possible anchoring points is just as important as the final peptide surface concentration.
Peptide−Liposome Interactions. The effects of liposome anchoring and peptide oxidation on the secondary structure were investigated using circular dichroism spectroscopy (CD).
The CD spectra were acquired using a peptide/maleimide ratio of 1:1 after 8 h of incubation to ensure that the contribution of the unconjugated peptides would be negligible. Reduced and unbound KIC in PBS buffer showed an α-helical content that increased when anchored to 5 mol % MPB-PE ( Figure 1D ). In the absence of liposomes ( Figure S8 ), the α-helical content of KIC also steadily increased, likely due to oxidation of the Cys, which further facilitated homodimerization. However, in the absence of liposomes the process was much slower and required about 3 days of incubation in PBS to show similar helicity as when incubated for 10 min with liposomes with 5 mol % MPB-PE. The secondary structure of free reduced and liposome-anchored KIC showed interesting differences, clearly seen when examining the ratio of the characteristic minima at 208 and 222 nm in the CD spectra (Θ 222/208 ). Reduced and unbound KIC showed Θ 222/208 = 0.81, which increased slightly to Θ 222/208 = 0.83 after 1 h of incubation in PBS. This ratio was significantly higher for KIC with 5 mol % MPB-PE liposomes (Θ 222/208 = 1.05) after only 10 min of incubation. Typically, well-defined coiled coils display Θ 222/208 > 1, 31 suggesting that KIC adopted a defined coiled coil structure when anchored to the liposome membrane. This is likely a consequence of peptides associating and homodimerizing either laterally in the lipid bilayer or by interactions between peptides anchored on separate liposomes. Interliposomal interactions promoted by peptide homodimerization were indicated by a drastic drop in the CD signal intensity over time, likely due to the aggregation of the liposomes. Aggregation was confirmed by dynamic light scattering (DLS) in samples containing KIC and 5 mol % MPB-PE liposomes ( Figure 2 ). The aggregation process was rapid, and an increase in the hydrodynamic radius was observed within minutes after KIC was added to the MPB-PE liposomes. The aggregate size increased over a period of 4 h, resulting in macroscopic precipitates visible by eye. The change in the secondary structure of KIC was likely a contributing factor to the liposome aggregation, and it cannot be determined if it also was a part of the liposome release mechanism.
Interestingly, while being efficient in releasing encapsulated CF, KVC did not show any defined secondary structure when anchored to MPB-PE liposomes ( Figure 1E ) despite being designed to adopt a coiled coil motif similar to that of KIC. 23, 24 Compared to KIC, KVC was less prone to homodimerize due to the substitution of Ile for Val in the hydrophobic core ( Figure S1 ) 23 and was thus more likely to partition into the lipid membrane to shield its hydrophobic residues, which induced a change in the liposome permeability. Commonly, the partitioning of amphipathic peptides into lipid membranes is accompanied by the formation of secondary structure, so-called partition-folding coupling. 32 This raises the question of whether KVC resides on the surface or inside the lipid bilayer or if only a small fraction of the peptides was inserted into the lipid bilayer, making the assessment of the change in secondary structure using CD spectroscopy difficult.
In contrast to KIC, no major changes in the hydrodynamic radius of liposomes with and without MPB-PE were seen upon addition of KVC ( Figure 2 ). Addition of KVC to MPB-PE liposomes resulted in a slight increase (1−15 nm) in the radius, likely as a result of the anchoring of the peptides to the liposomes. DLS did not show any smaller fragments (e.g., micelles) even at the highest peptide/maleimide ratio of 25:1 (50 μM KVC + 5 mol % MPB-PE, Figure S9 ) or a decrease in the count rate (241 and 245 kcps before and after peptide addition, respectively), indicating that the liposomes remained intact although there was a pronounced loss in membrane integrity as shown by the rapid CF release. These findings were further supported by surface plasmon resonance (SPR) data on liposomes tethered to a Biacore L1 chip (Figure 3 ). The injection of KVC over a surface with 5 mol % MPB-PE liposomes resulted in a response of 700−1200 RU (10 min contact time) corresponding to a surface concentration of peptides that correlated well with the quantity of available maleimides on the MPB-PE liposomes ( Figure 3B ). Since no loss of material could be observed during or after the anchoring of the peptides, a peptide−lipid interaction via a detergent-like carpet mechanism 33 seems unlikely. The injection of KIC over a surface with immobilized 5 mol % MPB-PE liposomes resulted in a higher degree of conjugation than expected considering the quantity of available maleimides. This further indicates that homodimerization between conjugated and unconjugated KIC can occur, resulting in the association and recruitment of additional peptides to the liposome surface. This effect was also previously observed for a related designed cationic amphipathic helix−loop−helix peptide studied under similar conditions but did not inhibit the release as was seen here. 13 In order to further elucidate the nature of the interaction between KVC and the lipid membrane, isothermal titration calorimetry (ITC) was carried out. The interpretation of the ITC data was complicated by the fact that both covalent and noncovalent interactions contribute. The addition of Cys alone to liposomes with 5 mol % MPB-PE showed a highly exothermic (ΔH = −0.57 kcal/mol) reaction as expected ( Figure S10 ). The final molar ratio of Cys to maleimides was roughly 4:5, which indicates that a majority of maleimides in the MPB-PE liposomes were available for binding, likely due to the transbilayer movement of mainly unconjugated and perhaps Cys-conjugated MPB-PE. 34 The addition of KVC to liposomes with 0 mol % MPB-PE indicated, as expected, no obvious interactions. Liposomes with 5 mol % MPB-PE, on the other hand, showed roughly 1:2 KVC/MPB-PE stoichiometry and an exothermic reaction (ΔH = −0.22 kcal/mol) with contributions from both the Cys-mediated peptide conjugation and physical peptide−lipid membrane interactions. The lower enthalpy for the binding of the peptide to the liposomes compared with Cys alone indicated that the peptide−lipid interaction was endothermic. The interaction with the lipid membrane was hence driven by a combination of a proximity effect caused by the formation of the covalent thiol−maleimide bond and a potential entropic gain upon membrane partitioning that is not fully compensated for in the Gibbs free energy of folding, resulting in a less pronounced partition-folding coupling as indicated by the CD spectra. Still, the association of the peptide with the lipid membrane resulted in a definite destabilization in lipid membrane integrity, which resulted in liposome release above a threshold concentration of anchored peptides.
Inhibition of Liposome Cargo Release by Peptide Heterodimerization. To further investigate the possibility to utilize specific peptide-mediated interactions to tune the release of CF, peptides EI and EV were used to introduce a competitive interaction. These experiments were done with KVC only since KIC showed such strong tendencies for homodimerization. Upon heterodimerization and folding of the peptides into coiled coils, the Cys residue in KVC will still be accessible for binding to the MPB-PE liposomes although the hydrophobic residues will no longer be available for interactions with the lipid bilayer. The release of encapsulated CF by KVC was consequently inhibited when KVC was first allowed to heterodimerize with charge-complementary peptide EI or EV prior to anchoring to liposomes ( Figure 4) . As the dimeric coiled coils are in equilibrium with their monomeric constituents a fraction of the peptides will, however, be capable of interacting with the lipid bilayer. The inhibitory effect was thus dependent on the affinity for heterodimerization. The higher the dissociation constant, the more of the anchored KVC that existed as monomers ( Figure S11 ) that could interact with the lipid membrane, causing release. The inhibition was thus always more effective when using EI as compared to EV at the same concentrations ( Figure 4B,C) . The CF release caused by 5 μM KVC was 45% in the absence of inhibitory peptides. The addition of EV (50 μM) reduced the CF release to 26% while EI (50 μM) reduced the release to 11% after 4 h of exposure to 5 mol % MPB-PE liposomes. Similar inhibitory results were obtained for 10 μM KVC where the release was 58% in the absence of EI and EV, which was reduced to 25 and 46% in the presence of EI and EV, respectively. The CF release caused by EI and EV alone was negligible (less than 5%) for all liposome compositions and peptide concentrations ( Figure  S5C ,D) strongly indicating that the anionic peptides did not interact with the lipid membrane. Moreover, when KVC was anchored to MPB-PE liposomes, a subsequent injection of either complementary peptide EI or EV resulted in very limited interactions between KVC and EI/ EV ( Figure 4D ,E and Figure S12 ). In contrast, when KVC was instead immobilized on a sensor chip with a carboxymethylated dextran matrix (Biacore CM5) and exposed to EI/EV, about 60% of the immobilized KVC peptides were in the heterodimeric state ( Figure 4E ). Liposome-anchored KVC was hence prevented from heterodimerizing with EI or EV despite the relatively high affinities for dimerization (K d (EIKV) = 0.072 μM and K d (EVKV) = 1.4 μM). 23 Note that this was also true for KVC attached to 1 mol % MPB-PE liposomes ( Figure 4E ), even though no increased membrane permeability was observed under these conditions ( Figure 1C ). This indicates that all bound KVC peptides have relatively strong interactions with lipids in the membrane, restricting access to interactions with the complementary peptides.
Heterodimer Exchange for Triggered Release. The association and folding of the coiled coils is a dynamic process, and the competitive interactions of dimerization and membrane partitioning, where the latter appears to be energetically more favorable, will eventually lead to the dissociation of the heterodimers. This process is slow and dependent on the dissociation rate of the heterodimeric complex. However, introducing a second competing interaction can enable the modulation of the dissociation rate of the membrane-bound heterodimers. The peptides used in this work were designed to be promiscuous, meaning that no negative design elements were introduced to prevent certain heterodimers from forming. Thus, on the basis of the four peptides, four different heterodimers can be obtained but with significant differences in affinities for dimerization. The differences in affinities result in social self-sorting of heterodimers in solution 23 but could also be utilized to dynamically dissociate the inhibiting EI peptide when associated with the liposome-anchored KVC. Additions of KI or KV to anchored heterodimers of EIKVC hence resulted in reactivation of the CF release in a concentration-dependent manner ( Figure 5 ). The addition of KV/KI at the same, or higher, concentrations as for the inhibiting peptide (EI) almost reestablished the release to the same level as in the control liposomes, i.e., without the addition of EI. At the time scales used here, i.e., 4 hours of incubation, both KV and KI showed about the same capacity to reactivate the release. In addition, the tendency of KI to homodimerize at RT ( Figures S7 and S8 and Aronsson et al. 23 ) could also slightly reduce its efficiency in promoting the heterodimer exchange.
The accelerated release upon addition of KV/KI is likely preceded by the formation of an intermediate peptide multimer, which was clearly indicated when investigating the interaction using SPR (Figure 6 ). Since KVC will not be accessible for heterodimerization after immobilization on liposomes, the heterodimer exchange was investigated using a sensor chip with a carboxymethylated dextran matrix (Biacore CM5). KVC was immobilized on the CM5 chip using thiol coupling. Subsequent injection of EI resulted in the formation of heterodimers that, under the flow conditions used here, started to dissociate immediately after the injection had finished. After an initially rapid dissociation, leaving about 200 RU of the heterodimers on the surface, a second injection of KI or KV resulted in a distinct association of peptides. The responses were comparable for both peptides and inversely proportional to the concentration of KV/KI. The higher the concentration of KV/KI, the faster the dissociation of the multimeric complex. Neither KV nor KI showed any association to immobilized KVC or to a Cys deactivated reference channel (data not shown). The association of intermediate multimers during the heterodimer exchange process was also seen when the anionic peptides were immobilized on the CM5 chips ( Figure S13 ).
■ CONCLUSIONS
The tailoring of liposome permeability is of great interest in drug delivery applications to ensure optimized release profiles. To this end, we have investigated the possibility to utilize a set of de novo-designed coiled coil polypeptides for tuning liposomal integrity. Cationic amphipathic peptides KIC and KVC were both found to trigger the release of liposomeencapsulated carboxyfluorescein (CF), but only when covalently anchored to the lipid membranes. The relatively small difference in sequence between KIC and KVC ( Figure S1 ) resulted in large differences in CF release, where KIC was more effective than KVC at low concentrations (0.1 μM < KIC/KVC < 5 μM). At higher concentrations, KIC showed a tendency toward homodimerization, which impaired the release and led to liposome aggregation. KVC, on the other hand, triggered almost complete CF release with only minor effects on liposomal size. Interestingly, despite clearly associating with the membrane, KVC remained a random coil, which is in contrast to other lipidated peptides with similar primary structures. 13, 35 Isothermal calorimetry revealed that the peptide−lipid interaction was endothermic and thus likely driven by proximity effects as a result of membrane anchoring and entropic gains upon membrane partitioning caused by the hydrophobic effect. The membrane-anchored peptides were not available for interactions with complementary peptide EI or EV, which further indicates membrane partitioning. However, allowing KVC to heterodimerize and fold with EV or EI prior to anchoring of the liposome leads to significant and concentration-dependent inhibition of the CF release. A subsequent addition of KI or KV led to the regain of the membrane-permeabilizing effect of KVC due to a heterodimer exchange, which likely was preceded by the formation of a membrane-bound multimeric peptide complex. In contrast to previous papers on peptide-mediated liposomal release exploiting either heating 12 or enzymatic interactions 20−22 as triggers, the current approach requires relatively low peptide surface concentrations and allows for multiple possibilities for tuning the release rate using defined and very specific interactions. The findings presented here thus delineate a new possible strategy for the further development of more sophisticated liposomal drug delivery systems.
■ EXPERIMENTAL SECTION
General. Lipids 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(4-(pmaleimidophenyl)butyramide) (MPB-PE) were acquired from Avanti Polar Lipids (Alabaster, AL, USA). Fmoc-protected amino acids and coupling reagents for solid-phase peptide synthesis were acquired from Iris Biotech GmbH (Marktredwitz, Germany). Sensor chips L1 and CM5 and all other chemicals and buffers needed for peptide immobilization and regeneration of the sensor surfaces were acquired from GE Healthcare (Uppsala, Sweden). All other chemicals were obtained from Sigma-Aldrich (St. Louis, MO, USA).
Peptide Synthesis. The peptide synthesis of EI, EV, KI, and KV was done in-house using the standard Fmoc solid-phase peptide synthesis protocol as previously described. 23 In short, the peptides were synthesized on a 0.1 mmol scale on rink amide resin (ChemMatrix, 0.47 mmol of NH 2 /resin) using 4 equiv of Fmocprotected amino acids, 4 equiv of HCTU, and 8 equiv of DIPEA. N- terminal acetylation was achieved by adding 10 mL of 1:1 (v/v) acetic anhydride/DMF after the final Fmoc deprotection. The peptides were cleaved from the resin using a 5 mL mixture of TFA/TIPS/MQ−water (9.5:0.25:0.25) (v/v) and incubated for 90 min. After filtration to remove the solid support, the resulting TFA/peptide mixtures were concentrated to 1 mL under a flow of N 2 . The peptides were then precipitated using −20°C diethyl ether and sequentially isolated using centrifugation. The crude peptides were purified using RP-HLPC on a Kromatek HiQ-Sil C18HS column under either acidic (KI and KV peptides) or alkaline (EI and EV peptides) conditions (peptide purity >95%). The final product's identity was confirmed using MALDI-ToF mass spectroscopy with α-cyano-hydroxycinnamic acid as a matrix. In addition, peptides with an N-terminal Cys residue (KIC and KVC) were ordered and custom-synthesized from GL Biochem Ltd. and used as received (peptide purity >95%).
Peptide Concentrations. Peptide concentrations were determined by measuring the absorbance at 280 nm (UV-2450 Shimadzu, Japan) by utilizing the tryptophan present in all sequences.
Liposome Preparation. Liposomes were prepared by thin film hydration and subsequent extrusion. The lipid composition was tailored by mixing MPB-PE and POPC, dissolved in chloroform, in molar ratios of 0:100, 1:99, and 5:95, resulting in 0, 1, and 5 mol % MPB-PE liposomes. Evaporation of the solvent was done first by a stream of nitrogen and then by vacuum desiccation overnight. Liposomes were formed by 10 min of rehydration of the dried lipid film with 0.01 M PBS (pH 7.4) followed by 1 min of vortex mixing. To decrease the size polydispersity, the liposomes were extruded 21 times through a 100 nm polycarbonate membrane using a miniextruder (Avanti Polar Lipids, USA). For CF-encapsulated liposomes, the dry lipid film was instead rehydrated with 50 mM CF (self-quenching concentration) in 10 mM PB and 90 mM NaCl (adjusted to pH 7.4). The liposome preparation was followed as described above with an additional final step of removing the unencapsulated CF by gel filtration using a PD-Mini/Miditrap G-25 column (GE Healthcare, Singapore) eluted with PBS buffer.
Carboxyfluorescein Leakage Assays. Carboxyfluorescein leakage assays were carried out by using liposomes with CF encapsulated at self-quenching concentration. Leakage was measured as increased fluorescence over time, λ ex = 485 nm and λ em = 520 nm, using a fluorescence platereader (BMG Fluostar Galaxy, Germany). The result is presented as the percentage of CF released at a chosen time point calculated as
where F 0 is the initial fluorescence intensity measured before the addition of any peptide, F is the fluorescence intensity at each time point, and F tot is the maximum fluorescence corresponding to the full release of CF, which was achieved by incubation with 1% Triton X-100. All samples were prepared using PBS buffer (pH 7.4), a total lipid concentration of 40 μM, and a final total volume of 250 μL in a 96-well plate and were measured in quadruplicate.
In the single-peptide experiment, peptide was added to the liposomes at time point 0 min. Each final peptide concentration was the result of the addition of an equal volume of peptide stocks. The final peptide concentrations were 0, 0.02, 0.05, 0.1, 0.2, 0.5, 1, 2, 5, 10, 20, and 50 μM, and CF release was measured every 2 min for 2 h. In the heterodimer experiment, KVC and EV or EI were preincubated for 30 min at RT before addition to liposomes, where all additions were of the same volume. Final peptide concentrations were 0, 5, and 10 μM KVC and 0, 1, 2, 5, 10, 20, and 50 μM EI or EV, and CF release was measured every 2 min for 2 h. In the heterodimer exchange, 5 μM KVC and 10 μM EI (final concentrations) were preincubated for 30 min at RT before addition to liposomes, followed by the addition of KI, all KI additions were of the same volume. Final concentrations of KI were 0, 1, 2, 5, 10, 20, and 50 μM, and CF release was measured every 2 min for 4 h.
Dynamic Light Scattering. Dynamic light scattering measurements were made to detect changes in liposome size upon additions of peptides. The size was determined by averaging at least 30 cycles of 10 s runs with a count rate of around 200 kcps and where the result was fitted to the cumulant model using the DLS function of a Zetasizer Nano ZS90 (Malvern, United Kingdom). Liposome and peptide concentrations were chosen to correspond to those of the CF leakage assays. In these experiments, 0, 0.5, 5, or 50 μM KIC or KVC was added to a solution of 40 μM lipid concentration plus 0, 1, or 5 mol % MPB-PE liposomes in PBS (pH 7.4). Samples were measured at 0 and 4 h at 25°C. Circular Dichroism Spectroscopy. Circular dichroism spectroscopy was carried out with a Chirascan (Applied Photophysics, United Kingdom) using a 1 mm cuvette, and the wavelength recorded was 197−280 nm. Each sample was prepared in PBS buffer (pH 7.4).
Samples with free peptide were prepared at 100 μM and incubated at RT for 0, 1, 8, 24, 72, and 168 h. Samples including liposomes were prepared using 50 μM peptide and 1 mM total lipids, chosen to achieve an equimolar ratio of thiol/maleimide in the sample with 5 mol % MPB-PE liposomes.
Surface Plasmon Resonance. Surface plasmon resonance measurements were made on a Biacore 3000 (GE Healthcare, Sweden) operated at 25°C. The flow rate was 10 μL/min, and PBS was used as the running buffer unless otherwise stated in individual steps.
An L1 sensor chip was used to evaluate peptide−lipid interactions. To minimize unspecific electrostatic binding to the sensor chip, the removal of negative charges in the dextran matrix was done with a 10 min injection of 250 μM EDC and 50 μM NHS, followed by a 3.5 min injection of 1 mM ethanolamine. Each measurement started with a wash with 2 × 30 s of isopropanol/50 mM NaOH 2:3 followed by a 15 min injection at 5 μL/min of 0, 1, or 5 mol % MPB-PE liposomes at 0.5 mM. To remove loosely bound liposomes, running buffer was allowed to flow at 100 μL/min for 5 min, followed by a 30 s injection of 10 μM NaOH. The peptide injections were always 10 min at 200 μM, and the postinjection phase was monitored for 10 min. The injection order was always EI/EV (reference injection), then KVC, and finally EI/EV. The measurement ended with a 2 × 30 s isopropanol/ 50 mM NaOH 2:3 regeneration step.
A CM5 sensor chip was used to evaluate peptide−peptide interactions and the heterodimer exchange. Ligands Cys, KIC, and KVC were immobilized in different flow channels on the sensor chip using thiol coupling. Immobilization started with a 30 s wash of 50 mM HCl followed by 10 min of 250 μM EDC and 50 μM NHS, 3.5 min of 18 mg/mL PDEA in 0.1 M borate buffer at pH 8.5, 3.5 min of 1 mM ethanolamine, 10 min of 10 μM ligand in acetate buffer at pH 5.5, 3.5 min in 100 μM Cys, and finally 2 × 30 s of 50 mM HCl to remove any unbound components. Each sample measurement started with a wash of 2 × 30 s of 50 mM NaOH followed by a 10 min injection of 10 μM EI, with dissociation monitored for 5 min and subsequent 10 min injections of 0, 1, 2, and 5 μM KI or KV. Finally, a 2 × 30 s injection of 50 mM NaOH was used to remove all noncovalently bound peptide.
Isothermal Titration Calorimetry. Isothermal titration calorimetry was done using a Microcal PEAQ-ITC (Malvern, United Kingdom). The experiments were performed by titrating 30 mM of 0 or 5 mol % MPB-PE liposomes into 150 μM Cys or KVC. Each injection was 3 μL, and the equilibration time between titrations was set to 5 min. The peaks corresponding to the injections were then integrated with respect to a fitted baseline in order to get the kcal/mol injectant.
■ ASSOCIATED CONTENT 
